107 related articles for article (PubMed ID: 14505678)
1. Design and synthesis of novel CCR3 antagonists.
Gong L; Hogg JH; Collier J; Wilhelm RS; Soderberg C
Bioorg Med Chem Lett; 2003 Oct; 13(20):3597-600. PubMed ID: 14505678
[TBL] [Abstract][Full Text] [Related]
2. 2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.
Watson PS; Jiang B; Harrison K; Asakawa N; Welch PK; Covington M; Stowell NC; Wadman EA; Davies P; Solomon KA; Newton RC; Trainor GL; Friedman SM; Decicco CP; Ko SS
Bioorg Med Chem Lett; 2006 Nov; 16(21):5695-9. PubMed ID: 16931001
[TBL] [Abstract][Full Text] [Related]
3. Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonists.
Pégurier C; Collart P; Danhaive P; Defays S; Gillard M; Gilson F; Kogej T; Pasau P; Van Houtvin N; Van Thuyne M; van Keulen B
Bioorg Med Chem Lett; 2007 Aug; 17(15):4228-31. PubMed ID: 17532633
[TBL] [Abstract][Full Text] [Related]
4. Strategy for the enantioselective synthesis of trans-2,4-disubstituted piperidines: application to the CCR3 antagonist IS811.
Kauffman GS; Watson PS; Nugent WA
J Org Chem; 2006 Nov; 71(23):8975-7. PubMed ID: 17081035
[TBL] [Abstract][Full Text] [Related]
5. Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists.
Varnes JG; Gardner DS; Santella JB; Duncia JV; Estrella M; Watson PS; Clark CM; Ko SS; Welch P; Covington M; Stowell N; Wadman E; Davies P; Solomon K; Newton RC; Trainor GL; Decicco CP; Wacker DA
Bioorg Med Chem Lett; 2004 Apr; 14(7):1645-9. PubMed ID: 15026042
[TBL] [Abstract][Full Text] [Related]
6. Discovery and structure-activity relationship of N-(ureidoalkyl)-benzyl-piperidines as potent small molecule CC chemokine receptor-3 (CCR3) antagonists.
De Lucca GV; Kim UT; Johnson C; Vargo BJ; Welch PK; Covington M; Davies P; Solomon KA; Newton RC; Trainor GL; Decicco CP; Ko SS
J Med Chem; 2002 Aug; 45(17):3794-804. PubMed ID: 12166951
[TBL] [Abstract][Full Text] [Related]
7. CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity.
Pruitt JR; Batt DG; Wacker DA; Bostrom LL; Booker SK; McLaughlin E; Houghton GC; Varnes JG; Christ DD; Covington M; Das AM; Davies P; Graden D; Kariv I; Orlovsky Y; Stowell NC; Vaddi KG; Wadman EA; Welch PK; Yeleswaram S; Solomon KA; Newton RC; Decicco CP; Carter PH; Ko SS
Bioorg Med Chem Lett; 2007 Jun; 17(11):2992-7. PubMed ID: 17418570
[TBL] [Abstract][Full Text] [Related]
8. The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists.
Ting PC; Lee JF; Wu J; Umland SP; Aslanian R; Cao J; Dong Y; Garlisi CG; Gilbert EJ; Huang Y; Jakway J; Kelly J; Liu Z; McCombie S; Shah H; Tian F; Wan Y; Shih NY
Bioorg Med Chem Lett; 2005 Mar; 15(5):1375-8. PubMed ID: 15713390
[TBL] [Abstract][Full Text] [Related]
9. N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists.
Batt DG; Houghton GC; Roderick J; Santella JB; Wacker DA; Welch PK; Orlovsky YI; Wadman EA; Trzaskos JM; Davies P; Decicco CP; Carter PH
Bioorg Med Chem Lett; 2005 Feb; 15(3):787-91. PubMed ID: 15664858
[TBL] [Abstract][Full Text] [Related]
10. Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency.
De Lucca GV; Kim UT; Vargo BJ; Duncia JV; Santella JB; Gardner DS; Zheng C; Liauw A; Wang Z; Emmett G; Wacker DA; Welch PK; Covington M; Stowell NC; Wadman EA; Das AM; Davies P; Yeleswaram S; Graden DM; Solomon KA; Newton RC; Trainor GL; Decicco CP; Ko SS
J Med Chem; 2005 Mar; 48(6):2194-211. PubMed ID: 15771462
[TBL] [Abstract][Full Text] [Related]
11. CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure-activity relationships.
Wacker DA; Santella JB; Gardner DS; Varnes JG; Estrella M; DeLucca GV; Ko SS; Tanabe K; Watson PS; Welch PK; Covington M; Stowell NC; Wadman EA; Davies P; Solomon KA; Newton RC; Trainor GL; Friedman SM; Decicco CP; Duncia JV
Bioorg Med Chem Lett; 2002 Jul; 12(13):1785-9. PubMed ID: 12067561
[TBL] [Abstract][Full Text] [Related]
12. The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.
Ting PC; Umland SP; Aslanian R; Cao J; Garlisi CG; Huang Y; Jakway J; Liu Z; Shah H; Tian F; Wan Y; Shih NY
Bioorg Med Chem Lett; 2005 Jun; 15(12):3020-3. PubMed ID: 15908209
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).
Ghosh S; Elder A; Guo J; Mani U; Patane M; Carson K; Ye Q; Bennett R; Chi S; Jenkins T; Guan B; Kolbeck R; Smith S; Zhang C; LaRosa G; Jaffee B; Yang H; Eddy P; Lu C; Uttamsingh V; Horlick R; Harriman G; Flynn D
J Med Chem; 2006 May; 49(9):2669-72. PubMed ID: 16640325
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1.
Dhanak D; Christmann LT; Darcy MG; Jurewicz AJ; Keenan RM; Lee J; Sarau HM; Widdowson KL; White JR
Bioorg Med Chem Lett; 2001 Jun; 11(11):1441-4. PubMed ID: 11378373
[TBL] [Abstract][Full Text] [Related]
15. Rodent selectivity of piperidine-4-yl-1H-indoles, a series of CC chemokine receptor-3 (CCR3) antagonists: insights from a receptor model.
Kriegl JM; Martyres D; Grundl MA; Anderskewitz R; Dollinger H; Rast G; Schmid B; Seither P; Tautermann CS
Bioorg Med Chem Lett; 2015 Jan; 25(2):229-35. PubMed ID: 25497216
[TBL] [Abstract][Full Text] [Related]
16. Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2.
Dhanak D; Christmann LT; Darcy MG; Keenan RM; Knight SD; Lee J; Ridgers LH; Sarau HM; Shah DH; White JR; Zhang L
Bioorg Med Chem Lett; 2001 Jun; 11(11):1445-50. PubMed ID: 11378374
[TBL] [Abstract][Full Text] [Related]
17. From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part II: Acyclic replacements for the (3S)-3-benzylpiperidine in a series of potent CCR3 antagonists.
Gardner DS; Santella JB; Tebben AJ; Batt DG; Ko SS; Traeger SC; Welch PK; Wadman EA; Davies P; Carter PH; Duncia JV
Bioorg Med Chem Lett; 2008 Jan; 18(2):586-95. PubMed ID: 18160284
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of N-substituted 4-(4-hydroxyphenyl)piperidines, 4-(4-hydroxybenzyl)piperidines, and (+/-)-3-(4-hydroxyphenyl)pyrrolidines: selective antagonists at the 1A/2B NMDA receptor subtype.
Guzikowski AP; Tamiz AP; Acosta-Burruel M; Hong-Bae S; Cai SX; Hawkinson JE; Keana JF; Kesten SR; Shipp CT; Tran M; Whittemore ER; Woodward RM; Wright JL; Zhou ZL
J Med Chem; 2000 Mar; 43(5):984-94. PubMed ID: 10715162
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel CCR3 selective antagonist.
Naya A; Kobayashi K; Ishikawa M; Ohwaki K; Saeki T; Noguchi K; Ohtake N
Bioorg Med Chem Lett; 2001 May; 11(9):1219-23. PubMed ID: 11354381
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of 2-(benzothiazolylthio)acetamide class of CCR3 selective antagonist.
Naya A; Kobayashi K; Ishikawa M; Ohwaki K; Saeki T; Noguchi K; Ohtake N
Chem Pharm Bull (Tokyo); 2003 Jun; 51(6):697-701. PubMed ID: 12808249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
